Evidence map›Paper›PMID 35811832›Full record

ArticleCase reports in critical care2022

Right Ventricular Clot in Transit in a Patient with Coronavirus Disease 2019 (COVID-19) Pneumonia Successfully Treated with Thrombolytics.

Yaman Alali, Ian Jackson, Abedel Rahman Anani, Marisa Varghese, Muhammad Ebrahim Khan, Suchitra Pilli

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in critical care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yaman AlaliDepartment of Medicine, Creighton University School of Medicine, Omaha, NE, USA.ORCID https://orcid.org/0000-0002-3538-5938
Ian JacksonDepartment of Medicine, Creighton University School of Medicine, Omaha, NE, USA.ORCID https://orcid.org/0000-0003-1878-1020
Abedel Rahman AnaniDepartment of Medicine, Creighton University School of Medicine, Omaha, NE, USA.
Marisa VargheseDepartment of Medicine, Creighton University School of Medicine, Omaha, NE, USA.
Muhammad Ebrahim KhanDepartment of Pulmonary and Critical Care, Creighton University School of Medicine, Omaha, NE, USA.
Suchitra PilliDepartment of Pulmonary and Critical Care, Creighton University School of Medicine, Omaha, NE, USA.
Creighton University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Right heart thrombus or clot in transit is a rare venous thromboembolism (VTE) with high mortality. COVID-19 infection has been associated with increased risk of such events. We present the case of a 63-year-old man with no traditional VTE risk factors who was diagnosed with a clot in transit three weeks after diagnosis of COVID-19. Conclusion: Clot in transit is rare but can occur in COVID-19 patients even in the absence of traditional thromboembolism risk factors. Management includes systemic anticoagulation, systemic thrombolysis, and surgical embolectomy. Our patient was successfully treated with systemic thrombolysis.

Identifiers

PMID35811832
PMCPMC9259549
OpenAlexW4284685623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.